Related Experiment Videos
Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons
Takashi Kanbayashi1, Tamami Yano, Hideaki Ishiguro
1Department of Neuropsychiatry, Akita University School of Medicine, Hondo, Japan. takashik@psy.med.akita-u.ac.jp
Insights
Cerebrospinal fluid (CSF) hypocretin-1 levels do not change with age or gender in humans, suggesting early maturation of hypocretin neurotransmission. These findings are crucial for understanding narcolepsy pathophysiology.
Area of Science:
- Neuroscience
- Sleep Medicine
- Biochemistry
Background:
- Narcolepsy is linked to hypocretin deficiency.
- Hypocretin-1 levels in CSF and brain are key indicators.
- Understanding age-related changes is important for disease pathophysiology.
Purpose of the Study:
- To investigate age-dependent changes in CSF hypocretin-1 concentrations.
- To determine if gender influences CSF hypocretin-1 levels.
Main Methods:
- CSF hypocretin-1 levels were measured in 272 participants (0-79 years).
- Analysis included comparisons across age groups and by gender.
- ANOVA was used to assess the influence of age and gender.
Main Results:
- No significant differences in CSF hypocretin-1 levels were found based on age or gender.
- Infant hypocretin-1 levels (under 4 months) were comparable to adult levels.
- Results held true despite a heterogeneous patient group with various conditions.
Conclusions:
- Hypocretin transmission appears to mature early in life.
- CSF hypocretin-1 levels show stability across the human lifespan.
- This stability suggests other factors may be more critical in narcolepsy development.
Study Objectives:
Recent CSF and postmortem brain hypocretin measurements in human narcolepsy suggest that hypocretin deficiency is involved in the pathophysiology of the disease. In this study, we measured CSF hypocretin-1 levels in various age ranges from infants to elder people to investigate the age-dependent change of hypocretin concentrations.
Design:
CSF hypocretin levels were compared by age groups and gender. ANOVA was used to examine the influences of these two parameters on CSF hypocretin levels.
Setting:
University-based sleep and biology laboratory.
Patients Or Participants:
Two hundred seventy two patients were included in this study, with 157 males and 115 females (0-79 years old).
Interventions:
CSF samples were obtained by lumber punctures with informed consents.
Measurements And Results:
Hypocretin-1 levels are not different in respect to gender or age, although our samples constitute a heterogeneous group with various disease conditions. CSF hypocretin-1 levels in infants under 4 months are similar to those in adults.
Conclusions:
Early maturation of hypocretin transmission is suggested. No age- or gender-dependent changes in CSF hypocretin is observed.